IXC 1.41% 7.0¢ invex therapeutics ltd

Ann: Appendix 4C - quarterly, page-2

  1. 17,583 Posts.
    lightbulb Created with Sketch. 429
    "The Company has already made significant progress in its development activities and as recently announced to the market expects top-line results for the Phase II trial in late Q1 2020 to early Q2 2020."

    cut and paste from quarterly
    a bit of a clue here ????


    expects top-line results
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.0¢
Change
-0.001(1.41%)
Mkt cap ! $5.260M
Open High Low Value Volume
7.0¢ 7.0¢ 7.0¢ $378 5.405K

Buyers (Bids)

No. Vol. Price($)
1 22915 7.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 22452 2
View Market Depth
Last trade - 10.04am 09/09/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.